CVS Health Dirección

Dirección controles de criterios 3/4

El CEO de CVS Health's es Karen Lynch , nombrado en Feb 2021, tiene una permanencia de 3.17 años. compensación anual total es $21.62M, compuesta por 6.9% salario y 93.1% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.04% de las acciones de la empresa, por valor de CLP32.50B. La antigüedad media del equipo directivo y de la junta directiva es de 2.1 años y 6.2 años, respectivamente.

Información clave

Karen Lynch

Chief Executive Officer (CEO)

US$21.6m

Compensación total

Porcentaje del salario del CEO	6.9%
Permanencia del CEO	3.3yrs
Participación del CEO	0.04%
Permanencia media de la dirección	2.2yrs
Promedio de permanencia en la Junta Directiva	6.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Karen Lynch en comparación con los beneficios de CVS Health?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	US$7b
Dec 31 2023	US$22m	US$2m	US$8b
Sep 30 2023	n/a	n/a	US$8b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$4b
Dec 31 2022	US$21m	US$1m	US$4b
Sep 30 2022	n/a	n/a	US$3b
Jun 30 2022	n/a	n/a	US$8b
Mar 31 2022	n/a	n/a	US$8b
Dec 31 2021	US$20m	US$1m	US$8b
Sep 30 2021	n/a	n/a	US$8b
Jun 30 2021	n/a	n/a	US$7b
Mar 31 2021	n/a	n/a	US$7b
Dec 31 2020	US$11m	US$1m	US$7b

Compensación vs. Mercado: La compensación total de Karen($USD21.62M) está por encima de la media de empresas de tamaño similar en el mercado CL ($USD6.04M).

Compensación vs. Ingresos: La compensación de Karen ha sido consistente con los resultados de la empresa en el último año.

CEO

Karen Lynch (60 yo)

3.3yrs

Permanencia

US$21,615,034

Compensación

Ms. Karen Sue Lynch serves as Chief Executive Officer, President and Director at CVS Health Corporation since February 01, 2021. She has extensive experience in the health care industry. She was Executive...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Karen Lynch	President	3.3yrs	US$21.62m	0.040% $ 26.4b
Thomas Cowhey	Executive VP & CFO	less than a year	US$4.58m	0.0028% $ 1.9b
Tilak Mandadi	Executive VP of Ventures and Chief Digital	1.8yrs	US$8.88m	0.0016% $ 1.1b
Samrat Khichi	Executive VP	1.3yrs	US$11.89m	0.00077% $ 507.1m
Prem Shah	Executive VP	2.5yrs	US$8.58m	0.0037% $ 2.4b
Vijay Patel	Senior Director of Business Development & CVS Health and Partner & Co-Founder	no data	sin datos	sin datos
James Clark	Senior VP	5.5yrs	sin datos	0.00067% $ 441.3m
Laurence McGrath	Senior Vice President of Business Development & Investor Relations	1.8yrs	sin datos	sin datos
David Falkowski	Executive VP & Chief Compliance Officer	no data	sin datos	sin datos
Laurie Havanec	Executive VP & Chief People Officer	3.3yrs	sin datos	0.0030% $ 2.0b
J. Joyner	Executive Vice President & President of CVS Caremark	1.3yrs	sin datos	0.0032% $ 2.1b
Michelle Peluso	Executive VP and Chief Customer & Experience Officer	3.3yrs	sin datos	0.0099% $ 6.5b

2.2yrs

Permanencia media

58yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de CVSCL se considera experimentado (2.1 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Karen Lynch	President	3.3yrs	US$21.62m	0.040% $ 26.4b
J. Kirby	Independent Director	less than a year	US$195.42k	0.00022% $ 144.9m
Edward Ludwig	Independent Director	5.5yrs	US$314.00k	0.0025% $ 1.7b
Roger Farah	Independent Chairman	5.5yrs	US$576.50k	0.00033% $ 217.3m
Mary Schapiro	Independent Director	7yrs	US$301.50k	0.00094% $ 619.1m
Nancy-Ann DeParle	Independent Director	10.7yrs	US$321.50k	0.0023% $ 1.5b
Anne Finucane	Independent Director	13.3yrs	US$321.50k	0.0026% $ 1.7b
C. Brown	Independent Director	17.2yrs	US$321.50k	0.0095% $ 6.2b
Jean-Pierre Millon	Independent Director	17.2yrs	US$321.50k	0.0085% $ 5.6b
Alecia DeCoudreaux	Independent Director	9.2yrs	US$301.50k	0.00024% $ 158.1m
Fernando Aguirre	Independent Director	5.5yrs	US$318.17k	0.0026% $ 1.7b
Jeffrey Balser	Independent Director	1.7yrs	US$301.50k	0.00040% $ 263.4m

6.3yrs

Permanencia media

67.5yo

Promedio de edad

Junta con experiencia: La junta directiva de CVSCL se considera experimentada (6.2 años de antigüedad promedio).

CVS Health Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Insider recently bought CL$478m worth of stock

CVS Health Corporation, Annual General Meeting, May 16, 2024

Executive VP recently sold CL$2.2b worth of stock

CVS Health Announces Executive Changes

Independent Director recently bought CL$124m worth of stock

CVS Health Names Mark Santos as President, Aetna Medicaid

Recent updates

Insider recently bought CL$478m worth of stock

First quarter 2024 earnings released: EPS: US$0.88 (vs US$1.67 in 1Q 2023)

CVS Health Corporation Revises Earnings Guidance for the Full Year 2024

Upcoming dividend of US$0.67 per share

CVS Health Corporation, Annual General Meeting, May 16, 2024

CVS Health Corporation to Report Q1, 2024 Results on May 01, 2024

Fourth quarter dividend of US$0.67 announced

Cvs Health Approves Quarterly Dividend on the Common Stock, Payable on May 1, 2024

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Executive VP recently sold CL$2.2b worth of stock

Full year 2023 earnings released: EPS: US$6.49 (vs US$3.16 in FY 2022)

Upcoming dividend of US$0.67 per share at 3.1% yield

CVS Health Corporation Provides Earnings Guidance for the Year 2023

CVS Health Announces Executive Changes

Robbins Geller Rudman & Dowd LLP and Aqualaw PLC Reaches Settlements in Class Action with Costco Wholesale Corporation, CVS Health Corporation, The Procter & Gamble Company, Target Corporation, Walgreen Co. and Walmart Inc

CVS Health Approves Quarterly Dividend, Payable on February 1, 2024

Independent Director recently bought CL$124m worth of stock

CVS Health Names Mark Santos as President, Aetna Medicaid

Independent Director recently bought CL$124m worth of stock

CVS Health Corporation Revises Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings released: EPS: US$1.76 (vs US$2.60 loss in 3Q 2022)

New major risk - Share price stability

CVS Health Announces CFO Changes

CVS Health Announces Executive Changes

Upcoming dividend of US$0.60 per share at 3.4% yield

CVS Health Approves Quarterly Dividend, Payable on November 1, 2023

CVS Health Corporation Updates Covid-19 Vaccine Now Available At CVS Pharmacy®

CVS Health Corporation Announces Additional Responsibilities for Executive Leadership Team Members

Senior VP recently sold CL$1.6b worth of stock

CVS Health Corporation to Report Q3, 2023 Results on Nov 01, 2023

CVS Health Corporation Revises Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings released: EPS: US$1.48 (vs US$2.25 in 2Q 2022)

Court Denies CVS's Motion To Escape Discrimination Lawsuit Brought By HIV-Positive "John Doe" Plaintiffs

CVS Pharmacy Introduces New Universal Tools Collection from One+Other

CVS Health Corporation Appoints Scott Kirby to Board of Directors, Effective October 1

Cvs Health Approves Quarterly Dividend on the Common Stock of the Corporation, Payable on August 1, 2023

CVS Health Corporation to Report Q2, 2023 Results on Aug 02, 2023

Now 44% undervalued after recent price drop

President recently bought CL$787m worth of stock

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad